Vaccines: Mexico first country to authorize Indian Covaxin

(ANSA) - MEXICO CITY, APRIL 07 - Mexico has approved the use of the Indian vaccine Covaxin thus becoming the first country in the world to authorize it to deal with the Covid-19 pandemic.

   The newspaper Jornada of Mexico City writes it today.

    The newspaper specifies that with the drug developed by the Bharat Biotech laboratory, there are now six vaccines available to the Mexican health authorities to tackle the coronavirus: the Indian Covaxin, the American Pfizer, the British AstraZeneca, the Russian Sputnik V and the Chinese CanSino and Sinovac.

    Mexican Foreign Minister Marcelo Ebrard, who will visit India in the next few days on a tour that will also take him to visit Russia, China and the United States, praised via Twitter the decision of the Federal Commission for the Protection against Health Risks (Cofepris) to approve the Indian vaccine calling it "very timely".

    In early March, Bharat Biotech, criticized for launching its vaccine even before the end of the experimental tests, argued in a statement that Covaxin not only "is 81% effective", but "shows a significant immunological response capacity against variants that emerge suddenly ".

    In Latin America, Brazil rejected its approval, while Paraguay, which received 100,000 doses of Covaxin from India, put them in 'quarantine' pending further scientific information on its effectiveness.

(HANDLE).